Covariate adjustment in cluster randomised trials with binar y outcomes focussing on relative risks and risk difference
整群随机试验中的协变量调整,二元结果侧重于相对风险和风险差异
基本信息
- 批准号:2893574
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:英国
- 项目类别:Studentship
- 财政年份:2023
- 资助国家:英国
- 起止时间:2023 至 无数据
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Randomised controlled trials frequently have binary primary outcomes yet methods for the analysis of binary outcomes is under researched. The CONSORT guideline for reporting of results from randomised trials recommends that for binary outcomes researchers report both relative and absolute measures of effect. Furthermore, when reporting relative measures of effect, because odds ratios are often misinterpreted as risk ratios and because risk ratios and odds ratios diverge as the prevalence of the outcome becomes increasingly less common, relative risks can be the preferred measure of quantifying effects on the relative scale. Whilst relative risks and risk differences are relatively straight forward to calculate without adjustment for any covariates, in practice covariate adjustment is often warranted either because of chance imbalance or to improve precision of the treatment effect. Methods to compute relative risks and risk difference whilst adjusting for covariates are more complex and have increased possibility of model non-convergence. In practice, researchers often fail to report absolute measures of effect and when reporting relative measures of effect do so using odds ratios. This is likely due to a multitude of reasons, but contributing factors include complexity of methods.Covariate adjustment in cluster randomised trials: There are a number of reasons why covariate adjustment is likely to be important in cluster randomised trials (CRTs). Firstly, in CRTs randomisation is at the level of the cluster, and individuals might be recruited after randomisation, meaning there can be important risks of "selection bias" (known as recruitment or identification biases) [Eldridge 2008]. These manifest as differences in the characteristics of individuals under treatment and control arms - and in extreme cases can render the trial more like an observational study [Bolzern 2018; Easter 2021]. Thus, in CRTs, covariate adjustment can have an important role of protecting against confounding [Leyrat 2014]. Furthermore, as under individual randomisation, even when the risk of selection bias is negligible (e.g., in studies with pre-randomisation recruitment), covariate adjustment might still improve statistical precision [Li 2016; Li 2017]. However, there are many nuances around covariate adjustment in cluster trials. For example, in CRTs, covariates might be measured at the level of the cluster, or individual, or both; and there can thus be important decisions around how the covariates are to be included [Begg 2003]. For example, cluster size is a typical stratification factor, often implemented using an historical measure of cluster size. At the analysis stage, questions can arise around what covariate should be adjusted in the analysis: the categorized historical version; or a more contemporary continuous version. Moreover, there are numerous ways to approach covariate adjustment in CRTs, including direct covariate adjustment using generalised linear mixed models or generalised estimating equations, propensity score approaches and marginal standardisation (also known simply as standardisation or G-computation) [Benkeset 2021; Morris 2022], or cluster-level analysis. What the studentship will encompassObjective: To establish a methodological framework for covariate adjustment in cluster randomised trials when estimating relative risks and risk differencesPlans for project:1. Review of the literature and case studya. Review of reporting and analytical approaches for covariate adjustment in CRTs for binary outcomes. This project will systematically review and document contemporary approaches to covariate adjustment in CRTs when reporting binary outcomes- considering how covariates are selected for inclusion; whether they are adjusted for at the level of the cluster or individual; as well as analytical approaches. This will inform WPs 1 and 2. b. Identification of several case studies to illustrate the methodology to imp
随机对照试验通常具有二元主要结局,但二元结局的分析方法仍在研究中。随机试验结果报告的CONSORT指南建议,对于二元结果,研究人员应报告相对和绝对效应指标。此外,在报告相对效应指标时,由于比值比经常被误解为风险比,并且由于风险比和比值比随着结果的流行率变得越来越不常见而出现分歧,因此相对风险可能是量化相对规模效应的首选指标。虽然相对风险和风险差异的计算相对简单,无需对任何协变量进行调整,但在实践中,由于机会不平衡或为了提高治疗效果的精确度,通常需要对协变量进行调整。计算相对风险和风险差异同时调整协变量的方法更加复杂,并且增加了模型不收敛的可能性。在实践中,研究人员往往无法报告绝对的效果措施,并在报告相对效果措施时使用比值比。这可能是由于多种原因,但促成因素包括方法的复杂性。整群随机试验中的协变量调整:有许多原因说明协变量调整在整群随机试验(CRT)中可能很重要。首先,在CRT中,随机化是在集群水平上进行的,个体可能在随机化后招募,这意味着可能存在“选择偏倚”(称为招募或识别偏倚)的重要风险[Eldridge 2008]。这些表现为治疗组和对照组个体特征的差异-在极端情况下,可能使试验更像是观察性研究[Bolzern 2018; Easter 2021]。因此,在CRT中,协变量调整可以在防止混淆方面发挥重要作用[Leyrat 2014]。此外,与个体随机化一样,即使选择偏倚的风险可以忽略不计(例如,在随机化前招募的研究中),协变量调整仍可能提高统计学精确度[Li 2016; Li 2017]。然而,在整群试验中,协变量调整存在许多细微差别。例如,在CRT中,协变量可能在集群或个体或两者的水平上进行测量;因此,围绕如何纳入协变量可能存在重要决策[Begg 2003]。例如,集群大小是一个典型的分层因素,通常使用集群大小的历史度量来实现。在分析阶段,可能会出现一些问题,比如在分析中应该调整哪些协变量:分类的历史版本;还是更现代的连续版本。此外,有许多方法可以在CRT中进行协变量调整,包括使用广义线性混合模型或广义估计方程进行直接协变量调整、倾向评分方法和边际标准化(也简称为标准化或G计算)[Benkeset 2021; Morris 2022]或聚类水平分析。目的:建立整群随机试验中估计相对危险度和危险度差异时协变量调整的方法学框架。文献回顾和案例研究a。审查CRT中二元结局协变量调整的报告和分析方法。本项目将系统地审查和记录CRT中报告二元结局时协变量调整的当代方法-考虑如何选择纳入的协变量;它们是否在集群或个体水平上进行调整;以及分析方法。这将通知WP 1和WP 2。B.确定几个案例研究,以说明改进
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
其他文献
吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('', 18)}}的其他基金
An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
- 批准号:
2901954 - 财政年份:2028
- 资助金额:
-- - 项目类别:
Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
- 批准号:
2896097 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
- 批准号:
2780268 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
- 批准号:
2908918 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
- 批准号:
2908693 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
- 批准号:
2908917 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
- 批准号:
2879438 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
- 批准号:
2890513 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
- 批准号:
2876993 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
相似海外基金
Genetic & Social Determinants of Health: Center for Admixture Science and Technology
遗传
- 批准号:
10818088 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Aligning Patient Acuity with Resource Intensity after Major Surgery
大手术后使患者的敏锐度与资源强度保持一致
- 批准号:
10635798 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Incorporating residential histories into assessment of cancer risk in a predominantly low-income and racially diverse population
将居住史纳入以低收入和种族多元化为主的人群的癌症风险评估中
- 批准号:
10735164 - 财政年份:2023
- 资助金额:
-- - 项目类别:
A Pragmatic Trial of the UCSF Brain Health Assessment for the Detection of Cognitive Impairment in Primary Care
加州大学旧金山分校脑健康评估用于检测初级保健中认知障碍的实用试验
- 批准号:
10705314 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Pediatric HIV Disclosure Benefits Study (PhD-BS) - Sankofa 2
儿科 HIV 披露福利研究 (PhD-BS) - Sankofa 2
- 批准号:
10440454 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Pediatric HIV Disclosure Benefits Study (PhD-BS) - Sankofa 2
儿科 HIV 披露福利研究 (PhD-BS) - Sankofa 2
- 批准号:
10240333 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Pediatric HIV Disclosure Benefits Study (PhD-BS) - Sankofa 2
儿科 HIV 披露福利研究 (PhD-BS) - Sankofa 2
- 批准号:
10082730 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Pediatric HIV Disclosure Benefits Study (PhD-BS) - Sankofa 2
儿科 HIV 披露福利研究 (PhD-BS) - Sankofa 2
- 批准号:
10662282 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Integrating novel GIS and GPS data to assess the impact of built environments on changes in BMI, physical activity and cancer-related biomarkers in two successful weight loss interventions in women at
整合新颖的 GIS 和 GPS 数据,评估建筑环境对 BMI、体力活动和癌症相关生物标志物变化的影响,在两项成功的女性减肥干预措施中
- 批准号:
10617201 - 财政年份:2019
- 资助金额:
-- - 项目类别:
A population based approach to improve outcomes after out-of hospital cardiac arrest
基于人群的方法改善院外心脏骤停后的结果
- 批准号:
9324446 - 财政年份:2016
- 资助金额:
-- - 项目类别: